Molecular Mechanisms of Cardiovascular Toxicity of Targeted Cancer Therapeutics

Circulation Research - United States
doi 10.1161/circresaha.109.206920
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Redox-Directed Cancer Therapeutics: Molecular Mechanisms and Opportunities

Antioxidants and Redox Signaling
Cell BiologyMolecular BiologyBiochemistryClinical BiochemistryMedicinePhysiology
2009English

Cardio-Oncology: Mechanisms of Cardiovascular Toxicity

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2018English

Reduced Toxicity Breast Cancer Therapy: Changing the or to and in Dual Targeted Therapeutics

2010English

Targeted Therapeutics

Cell
BiochemistryGeneticsMolecular Biology
2011English

CRADA Final Report: ErbB2 Targeted Cancer Therapeutics

2002English

Molecular Targeted Treatment of Metastatic Colorectal Cancer: The Cardiovascular Adverse Effects of Bevacizumab and Cetuximab

Medicine and Pharmacy Reports
Medicine
2017English

Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics

International Journal of Cell Biology
Cell Biology
2015English

RNA-Targeted Therapeutics

Cell Metabolism
Cell BiologyMolecular BiologyPhysiology
2019English

Cancer Targeted Therapeutics: From Molecules to Drug Delivery Vehicles

Journal of Controlled Release
Pharmaceutical Science
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy